A practical in vitro growth inhibition assay for the evaluation of TB vaccines

Vaccine

Volumn 28, Issue 2, 2009, Pages 317-322

  Kolibab, Kristopher ^a   Parra, Marcela ^a   Yang, Amy L ^a   Perera, Liyanage P ^b   Derrick, Steven C ^a   Morris, Sheldon L ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cytokines; In vitro assay; Mouse; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; ISONIAZID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG DETERMINATION; DRUG FORMULATION; EVOKED RESPONSE; FEMALE; GROWTH INHIBITION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG TUBERCULOSIS; MACROPHAGE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

ANIMALS; FEMALE; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA;

EID: 70649085830     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.047     Document Type: Article

References (26)

1. WHO. Global tuberculosis control - surveillance, planning, financing (2008), WHO/HTM/TB p. 393
2. LoBue P. Extensively drug-resistant tuberculosis. Curr Opin Infect Dis 22 2 (2009) 167-173
3. Colditz G.A., Brewer T., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 9 (1994) 698-702
4. Flynn J. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinburg) 84 1-2 (2004) 93-101
5. Cooper A. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27 (2009) 393-422
6. Cheon S.H., Kampmann B., Hise A.G., Phillips M., Song H.Y., Landen K., et al. Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis. Clin Diagn Lab Immunol 9 4 (2002) 901-907
7. Hoft D.F., Worku S., Kampmann B., Whalen C.C., Ellner J.J., Hirsch C.S., et al. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis 186 10 (2002) 1448-1457
8. Silver R.F., Li Q., Boom W.H., and Ellner J.J. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. J Immunol 160 5 (1998) 2408-2417
9. Worku S., and Hoft D.F. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin. Clin Infect Dis 30 Suppl. 3 (2000) S257-S261
10. Kampmann B., Gaora P., Snewin V.A., Gares M.P., Young D.B., and Levin M. Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. J Infect Dis 182 3 (2000) 895-901
11. Parra M., Yang A., Lim J., Kolibab K., Derrick S., Cadieux N., et al. The development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis. Clin Vaccine Immunol 16 7 (2009) 1025-1032
12. Derrick S.C., Yang A., and Morris S.L. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23 6 (2004) 780-788
13. Perera P.Y., Derrick S.C., Kolibab K., Momoi F., Yamamoto M., Morris S.L., et al. A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine 27 15 (2009) 2121-2127
14. Rouse D.A., and Morris S.L. Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. Infect Immun 63 4 (1995) 1427-1433
15. Lim J., Derrick S.C., Kolibab K., Yang A.L., Porcelli S., Jacobs W.R., et al. Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array. Clin Vaccine Immunol 16 1 (2009) 122-126
16. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 6 (1993) 2249-2254
17. Cowley S.C., and Elkins K.E. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med 198 3 (2003) 379-389
18. Cowley S.C., and Elkins K.E. CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J Immunol 171 9 (2003) 4689-4699
19. Cowley S.C., Hamilton E., Frelinger J.A., Su J., Forman J., and Elkins K.L. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. J Exp Med 202 2 (2005) 309-319
20. Robinson H.L., Sharma S., Zhao J., Kannanganat S., Lai L., Chennareddi L., et al. Immunogenicity in macaques of the clinical product for a clade B DNA/MVA HIV vaccine: elicitation of IFN-gamma, IL-2, and TNF-alpha coproducing CD4 and CD8 T cells. AIDS Res Hum Retroviruses 23 12 (2007) 1555-1562
21. Hawkridge T., Scriba T., Gelderbloem S., Smit E., Tameris M., Moyo S., et al. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis 198 4 (2008) 544-552
22. Burgers W.A., Chege G., Müller T.L., van Harmelen J.H., Khoury G., Shephard E.G., et al. Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons. J Gen Virol 90 Pt 2 (2009) 468-480
23. Darrah P.A., Patel D., De Luca P.M., Lindsay R.W., Davey D.F., Flynn B.J., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13 7 (2007) 843-850
24. Mollenkopf H.J., Hahnke K., and Kaufmann S.H. Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Microbes Infect 8 1 (2006) 136-144
25. Sinsimer D., Huet G., Manca C., Tsenova L., Koo M.S., Kurepina N., et al. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun 76 7 (2008) 3027-3036
26. Sada-Ovalle I., Chiba A., Gonzales A., Brenner M.B., and Behar S.M. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog 4 12 (2008) e1000239